RAPS: UK on Brexit Implications: ‘Significant Benefits’ to Remain Part of EMA
23.03.2017
The UK government’s EU External Affairs Subcommittee on Tuesday published a report on the implications of Brexit on trade, noting that there may be “significant benefits” in continuing UK participation in the European Medicines Agency (EMA).
SciencePharma
